MARKET INTRODUCTION
Naltrexone HCl is a type of opioid antagonist used to reduce, block and reverse the effects of intravenously administered opioids or accidentally taken opioids. Naltrexone HCl is also used in treatment program of drug abuse and also given in alcohol abuse. Naltrexone HCL is generally given by oral route with or without food. The side effects of naltrexone HCL include, nausea, dizziness, anxiety, abdominal cramps, and joint pain.
MARKET DYNAMICS
The key market drivers for Naltrexone HCl Market Includes, rising incidences of alcohol dependency and alcohol abuse along with increasing cases of narcotic drug abuse. Whereas, potential side effects from naltrexone HCL treatment such as nausea, dizziness, abdominal cramp are expected to restrain market growth during forecast period.
MARKET SCOPE
The "Naltrexone HCl Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Naltrexone HCl market with detailed market segmentation by type and applications. The Naltrexone HCl Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Naltrexone HCl Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Naltrexone HCl Market is segmented on the basis of type and applications. On the basis of type the market is segmented as, medical grade and others. On the basis of applications the market is segmented as, opioid independence, alcohol independence.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Naltrexone HCl Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Naltrexone HCl Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Naltrexone HCl Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Naltrexone HCl Market in these regions.
MARKET PLAYERS
The report covers key developments in the Naltrexone HCl Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Naltrexone HCl Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Naltrexone HCl market in the global market. Below mentioned is the list of few companies engaged in the Naltrexone HCl Market.
The report also includes the profiles of key players in Naltrexone HCl Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
Teva Pharmaceutical Industries, Ltd.
Ascent Scientific Ltd.
Adooq bioscience LLC
Mallinckrodt Pharmaceuticals
Sun Pharmaceutical Industries Limited
Sanofi
Taj Pharmaceuticals
Sigma-Aldrich
Sun Pharma
Humco
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Naltrexone HCl Market - By Type
1.3.2 Naltrexone HCl Market - By Applications
1.3.3 Naltrexone HCl Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NALTREXONE HCL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NALTREXONE HCL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NALTREXONE HCL MARKET - GLOBAL MARKET ANALYSIS
6.1. NALTREXONE HCL - GLOBAL MARKET OVERVIEW
6.2. NALTREXONE HCL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NALTREXONE HCL MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEDICAL GRADE
7.3.1. Overview
7.3.2. Medical Grade Market Forecast and Analysis
7.4. OTHERS
7.4.1. Overview
7.4.2. Others Market Forecast and Analysis
8. NALTREXONE HCL MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. OPIOID INDEPENDENCE
8.3.1. Overview
8.3.2. Opioid Independence Market Forecast and Analysis
8.4. ALCOHOL INDEPENDENCE
8.4.1. Overview
8.4.2. Alcohol Independence Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. NALTREXONE HCL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Naltrexone HCl Market Overview
9.1.2 North America Naltrexone HCl Market Forecasts and Analysis
9.1.3 North America Naltrexone HCl Market Forecasts and Analysis - By Type
9.1.4 North America Naltrexone HCl Market Forecasts and Analysis - By Applications
9.1.5 North America Naltrexone HCl Market Forecasts and Analysis - By Countries
9.1.5.1 United States Naltrexone HCl Market
9.1.5.1.1 United States Naltrexone HCl Market by Type
9.1.5.1.2 United States Naltrexone HCl Market by Applications
9.1.5.2 Canada Naltrexone HCl Market
9.1.5.2.1 Canada Naltrexone HCl Market by Type
9.1.5.2.2 Canada Naltrexone HCl Market by Applications
9.1.5.3 Mexico Naltrexone HCl Market
9.1.5.3.1 Mexico Naltrexone HCl Market by Type
9.1.5.3.2 Mexico Naltrexone HCl Market by Applications
9.2. EUROPE
9.2.1 Europe Naltrexone HCl Market Overview
9.2.2 Europe Naltrexone HCl Market Forecasts and Analysis
9.2.3 Europe Naltrexone HCl Market Forecasts and Analysis - By Type
9.2.4 Europe Naltrexone HCl Market Forecasts and Analysis - By Applications
9.2.5 Europe Naltrexone HCl Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Naltrexone HCl Market
9.2.5.1.1 Germany Naltrexone HCl Market by Type
9.2.5.1.2 Germany Naltrexone HCl Market by Applications
9.2.5.2 France Naltrexone HCl Market
9.2.5.2.1 France Naltrexone HCl Market by Type
9.2.5.2.2 France Naltrexone HCl Market by Applications
9.2.5.3 Italy Naltrexone HCl Market
9.2.5.3.1 Italy Naltrexone HCl Market by Type
9.2.5.3.2 Italy Naltrexone HCl Market by Applications
9.2.5.4 Spain Naltrexone HCl Market
9.2.5.4.1 Spain Naltrexone HCl Market by Type
9.2.5.4.2 Spain Naltrexone HCl Market by Applications
9.2.5.5 United Kingdom Naltrexone HCl Market
9.2.5.5.1 United Kingdom Naltrexone HCl Market by Type
9.2.5.5.2 United Kingdom Naltrexone HCl Market by Applications
9.2.5.6 Rest of Europe Naltrexone HCl Market
9.2.5.6.1 Rest of Europe Naltrexone HCl Market by Type
9.2.5.6.2 Rest of Europe Naltrexone HCl Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Naltrexone HCl Market Overview
9.3.2 Asia-Pacific Naltrexone HCl Market Forecasts and Analysis
9.3.3 Asia-Pacific Naltrexone HCl Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Naltrexone HCl Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Naltrexone HCl Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Naltrexone HCl Market
9.3.5.1.1 Australia Naltrexone HCl Market by Type
9.3.5.1.2 Australia Naltrexone HCl Market by Applications
9.3.5.2 China Naltrexone HCl Market
9.3.5.2.1 China Naltrexone HCl Market by Type
9.3.5.2.2 China Naltrexone HCl Market by Applications
9.3.5.3 India Naltrexone HCl Market
9.3.5.3.1 India Naltrexone HCl Market by Type
9.3.5.3.2 India Naltrexone HCl Market by Applications
9.3.5.4 Japan Naltrexone HCl Market
9.3.5.4.1 Japan Naltrexone HCl Market by Type
9.3.5.4.2 Japan Naltrexone HCl Market by Applications
9.3.5.5 South Korea Naltrexone HCl Market
9.3.5.5.1 South Korea Naltrexone HCl Market by Type
9.3.5.5.2 South Korea Naltrexone HCl Market by Applications
9.3.5.6 Rest of Asia-Pacific Naltrexone HCl Market
9.3.5.6.1 Rest of Asia-Pacific Naltrexone HCl Market by Type
9.3.5.6.2 Rest of Asia-Pacific Naltrexone HCl Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Naltrexone HCl Market Overview
9.4.2 Middle East and Africa Naltrexone HCl Market Forecasts and Analysis
9.4.3 Middle East and Africa Naltrexone HCl Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Naltrexone HCl Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Naltrexone HCl Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Naltrexone HCl Market
9.4.5.1.1 South Africa Naltrexone HCl Market by Type
9.4.5.1.2 South Africa Naltrexone HCl Market by Applications
9.4.5.2 Saudi Arabia Naltrexone HCl Market
9.4.5.2.1 Saudi Arabia Naltrexone HCl Market by Type
9.4.5.2.2 Saudi Arabia Naltrexone HCl Market by Applications
9.4.5.3 U.A.E Naltrexone HCl Market
9.4.5.3.1 U.A.E Naltrexone HCl Market by Type
9.4.5.3.2 U.A.E Naltrexone HCl Market by Applications
9.4.5.4 Rest of Middle East and Africa Naltrexone HCl Market
9.4.5.4.1 Rest of Middle East and Africa Naltrexone HCl Market by Type
9.4.5.4.2 Rest of Middle East and Africa Naltrexone HCl Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Naltrexone HCl Market Overview
9.5.2 South and Central America Naltrexone HCl Market Forecasts and Analysis
9.5.3 South and Central America Naltrexone HCl Market Forecasts and Analysis - By Type
9.5.4 South and Central America Naltrexone HCl Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Naltrexone HCl Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Naltrexone HCl Market
9.5.5.1.1 Brazil Naltrexone HCl Market by Type
9.5.5.1.2 Brazil Naltrexone HCl Market by Applications
9.5.5.2 Argentina Naltrexone HCl Market
9.5.5.2.1 Argentina Naltrexone HCl Market by Type
9.5.5.2.2 Argentina Naltrexone HCl Market by Applications
9.5.5.3 Rest of South and Central America Naltrexone HCl Market
9.5.5.3.1 Rest of South and Central America Naltrexone HCl Market by Type
9.5.5.3.2 Rest of South and Central America Naltrexone HCl Market by Applications
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NALTREXONE HCL MARKET, KEY COMPANY PROFILES
11.1. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASCENT SCIENTIFIC LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ADOOQ BIOSCIENCE LLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MALLINCKRODT PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SUN PHARMACEUTICAL INDUSTRIES LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SANOFI
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUN PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TAJ PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. HUMCO
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SIGMA-ALDRICH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Teva Pharmaceutical Industries Ltd
2. Ascent Scientific Ltd
3. Adooq Bioscience LLC
4. Mallinckrodt Pharmaceuticals
5. Sun Pharmaceutical Industries Limited
6. Sanofi
7. Sun Pharmaceuticals
8. Taj Pharmaceuticals
9. Humco
10. Sigma-Aldrich